Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5

Journal of Virology

Volumn 75, Issue 7, 2001, Pages 3462-3468

  Shioda, T ^a   Nakayama, E E ^a   Tanaka, Y ^a   Xin, X ^a   Liu, H ^a   Kawana Tachikawa, A ^a   Kato, A ^a   Sakai, Y ^a   Nagai, Y ^a   Iwamoto, A ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DELETION MUTANT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STROMA CELL; VIRUS REPLICATION; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; BIOLOGICAL TRANSPORT; CYTOPLASM; HELA CELLS; HIV-1; HUMANS; JURKAT CELLS; MUTATION; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 0035108034     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.7.3462-3468.2001     Document Type: Article

References (59)

1. CC-CKR5: A RANTES. MIP-1α, MIP-1β receptor as a fusion cofactors for macrophage-tropic HIV-1
2. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
3. The extent of genetic variation in the CCR5 gene
4. HIV blocked by chemokine antagonist
5. Replicative properties of human immunodeficiency viruses from patients with varying severity of HIV infection
6. CCR5 (+) and CXCR3 (+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
7. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32
8. HIV-1 phenotype classified by co-receptor usage
9. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
10. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
11. Novel alleles of the chemokine-receptor gene CCR5
12. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails
13. Natural infection of a homozygous delta 24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency, virus
14. Biologic features of HIV-1 that correlate with virulence in the host
15. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
16. Identification of RANTES. MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
17. + lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
18. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study. Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
19. Identification of a major co-receptor for primary isolates of HIV-1
20. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
21. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
22. HIV-1 entry cofactor: Functional eDNA cloning of a seven-transmembrane, G protein-coupled receptor
23. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication
24. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity
25. Association of CCR5 delta32 with reduced risk of asthma
26. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus
27. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
28. Dissociation of ligand-induced internalization of CXCR-4 from its co-receptor activity for HIV-1 Env-mediated membrane fusion
29. Initiation of sendai virus multiplication from transfected cDNA or RNA with negative or positive sense
30. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
31. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
32. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
33. The construction and characterization of vaccinia virus recombinants expressing foreign genes
34. Novel variant of the CCR5 gene in a Vietnamese population
35. Genetic acceleration of AIDS progression by a promoter variant of CCR5
36. Use of chemokine receptors by poxviruses
37. CCR5 promoter polymorphism and HIV-1 disease progression
38. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
39. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
40. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion
41. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion dependent reporter gene activation
42. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
43. Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus
44. Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus
45. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry
46. The chemokine receptor CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
47. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
48. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1
49. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells
50. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
51. CCR5 delta32, matrix metalloproteinase-9 and disease activity of multiple sclerosis
52. Production of human immunodeficiency virus type 1 (HIV-1) like particles from cells infected with a recombinant vaccinia virus expressing gag gene of HIV-1
53. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). ALIVE Study
54. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality
55. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
56. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
57. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene: Evidence for the role of the carboxyl-terminal tail in receptor trafficking
58. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro
59. Genotypic and phenotypic characterization of HIV-1 patients with primary infection